Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis.

Journal of experimental & clinical cancer research : CR - 3 Nov 2013

Peng Qiliu, Mo Cuiju, Qin Aiping, Lao Xianjun, Chen Zhiping, Sui Jingzhe, Wu Junrong, Zhai Limin, Yang Shi, Qin Xue, Li Shan

Abstract excerpt

OBJECTIVE: The SNP309 polymorphism (T-G) in the promoter of MDM2 gene has been reported to be associated with enhanced MDM2 expression and tumor development. Studies investigating the association between MDM2 SNP309 polymorphism and endometrial cancer risk reported conflicting results. We performed a meta-analysis of all available studies to explore this association. METHODS: All studies published up to August...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Endometrial Neoplasms
Share to MDM2 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Polymorphism, Single Nucleotide

Share to Proto-Oncogene Proteins c-mdm2

Share to Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 24423195
DOI: 10.1186/1756-9966-32-85
PMCID: PMC4029393

Genes

MDM2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis.PMID 24423195Read ↗

MDM2 SNP309 is associated with endometrial cancer susceptibility: a meta-analysis.Semantic proximity Read ↗

Relationship Between Murine Double Minute 2 (MDM2) T309G Polymorphism and Endometrial Cancer Risk: A Meta-Analysis.Semantic proximity Read ↗

Common variant on MDM2 contributes to endometrial cancer susceptibility: evidence based on 7 studies.Semantic proximity Read ↗

Association between a functional single nucleotide polymorphism in the MDM2 gene and sporadic endometrial cancer risk.Semantic proximity Read ↗

Association between MDM2 SNP309 polymorphism and endometrial cancer risk in Polish women.Semantic proximity Read ↗

MDM2 SNP309 is associated with endometrial cancer risk.Semantic proximity Read ↗

MDM2 SNP309 contributes to tumor susceptibility: a meta-analysis.Semantic proximity Read ↗

An updated meta-analysis on the association of MDM2 SNP309 polymorphism with colorectal cancer risk.Semantic proximity Read ↗

MDM2 SNP309 polymorphism and colorectal cancer risk: a meta-analysis.Semantic proximity Read ↗

MDM2 SNP309 variation increases cervical cancer risk among Asians.Semantic proximity Read ↗

Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer.Semantic proximity Read ↗

Current evidence on the relationship between SNP309 polymorphism in the MDM2 gene and colorectal cancer risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.